Go Pro
NASDAQ:INBS

Intelligent Bio Solutions (INBS) Stock Price, News & Analysis

Intelligent Bio Solutions logo
$1.72 -0.03 (-1.71%)
Closing price 07/27/2026 04:00 PM Eastern
Extended Trading
$1.80 +0.08 (+4.36%)
As of 07/27/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Intelligent Bio Solutions Stock (NASDAQ:INBS)

Advanced

Key Stats

Today's Range
$1.71
$1.85
50-Day Range
$1.72
$3.29
52-Week Range
$1.58
$24.90
Volume
27,160 shs
Average Volume
80,135 shs
Market Capitalization
$4.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Intelligent Bio Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

INBS MarketRank™: 

Intelligent Bio Solutions scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Intelligent Bio Solutions has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Intelligent Bio Solutions has only been the subject of 2 research reports in the past 90 days.

  • Read more about Intelligent Bio Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for Intelligent Bio Solutions are expected to decrease in the coming year, from ($3.42) to ($5.18) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Intelligent Bio Solutions is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Intelligent Bio Solutions is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Intelligent Bio Solutions has a P/B Ratio of 0.42. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Intelligent Bio Solutions' valuation and earnings.
  • Percentage of Shares Shorted

    4.38% of the float of Intelligent Bio Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Intelligent Bio Solutions has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Intelligent Bio Solutions has recently increased by 21.34%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Intelligent Bio Solutions does not currently pay a dividend.

  • Dividend Growth

    Intelligent Bio Solutions does not have a long track record of dividend growth.

  • News Sentiment

    Intelligent Bio Solutions has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.91 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Intelligent Bio Solutions this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    1.27% of the stock of Intelligent Bio Solutions is held by insiders.

  • Percentage Held by Institutions

    32.97% of the stock of Intelligent Bio Solutions is held by institutions.

  • Read more about Intelligent Bio Solutions' insider trading history.
Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INBS Stock News Headlines

Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.tc pixel
INBS Share News Today
See More Headlines

INBS Stock Analysis - Frequently Asked Questions

Intelligent Bio Solutions' stock was trading at $9.53 at the start of the year. Since then, INBS stock has decreased by 82.0% and is now trading at $1.72.

Intelligent Bio Solutions Inc. (NASDAQ:INBS) issued its earnings results on Wednesday, May, 13th. The company reported ($1.80) earnings per share (EPS) for the quarter, missing the consensus estimate of $1.40 by $3.20. The company had revenue of $1.06 million for the quarter, compared to the consensus estimate of $7.20 million. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 176.09% and a negative net margin of 296.73%.

Intelligent Bio Solutions shares reverse split before market open on Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Intelligent Bio Solutions (INBS) raised $22 million in an initial public offering on Wednesday, December 23rd 2020. The company issued 1,270,589 shares at a price of $16.00-$18.00 per share.

Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include SoFi Technologies (SOFI), Plug Power (PLUG), Allarity Therapeutics (ALLR), Adial Pharmaceuticals (ADIL), AMC Entertainment (AMC), ARMOUR Residential REIT (ARR) and BIOLASE (BIOL).

Company Calendar

Last Earnings
5/13/2026
Today
7/27/2026
Next Earnings (Estimated)
8/21/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:INBS
Previous Symbol
NASDAQ:GBS
CIK
1725430
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($12.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.57 million
Net Margins
-296.73%
Pretax Margin
-297.75%
Return on Equity
-176.09%
Return on Assets
-89.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.11
Quick Ratio
1.99

Sales & Book Value

Annual Sales
$3.05 million
Price / Sales
1.35
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.07 per share
Price / Book
0.42

Miscellaneous

Outstanding Shares
2,390,000
Free Float
2,362,000
Market Cap
$4.11 million
Optionable
Not Optionable
Beta
4.18
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:INBS) was last updated on 7/28/2026 by MarketBeat.com Staff.
From Our Partners